American Journal of Medicine and Medical Sciences

p-ISSN: 2165-901X     e-ISSN: 2165-9036

2011;  1(1): 1-6

doi: 10.5923/j.ajmms.20110101.01

Antioxidants Status in Acute Lymphoblastic Leukemic Patients

Copyright © 2011 Scientific & Academic Publishing. All Rights Reserved.

Abstract

ALL is the most common form of childhood cancer. Sufferers are treated with chemotherapy, which is associated with the production of free radicals. The aim of this study was to investigate the oxidative stress markers and some antioxidants status among Acute Lymphoblastic Leukemia patients. This study included 40 children newly diagnosed ALL before chemotherapy (mean age, 8.2 ±2) compared to 20 healthy controls (mean age, 7.6 ±1.4). The same of 40 patients of ALL undergoing chemotherapy treatment for 3 months. Oxidative stress, blood antioxidants status, kidney and liver profiles were measured in all groups. Our results showed that Antioxidants levels and Hb were significant decreased in ALL patients (P > 0.05) compared to control group, then antioxidants levels were more significant decreasing after ALL patients undergoing chemotherapy. In contrast MDA, 8dG, leukocytes count and Lymphoblast were significant increased (P > 0.05) compared to control group. Also, Urea and creatinine levels were found no significant difference between different groups, there was mild increase after chemotherapy but not significant. On other hand, ALT and AST were found no significant difference between healthy control and ALL patients. But their levels were found statistically significant to be increased in ALL patients after chemotherapy compared to before chemotherapy. In. conclusion, there are possible link between decreased antioxidants and increased levels of cells alterations due to oxidative damage in ALL, and this appear to be associated with complications of treatment

Keywords: Antioxidant, Acute Lymphoblastic Leukemia, Oxidative Stress, Antioxidant Status and Chemotherapy

Paper's body in HTML will come soon.

Reference

[1]  Aebi H (1984): "Catalase in vitro". Meth. Enzymol. 105: 121–6
[2]  Battisti V, Maders LD, Bagatini MD, Santos KF, Spanevello M, Maldonado PA, Brulé AO,Araújo Mdo C, Schetinger MR, Morsch VM. (2008): Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin Biochem.vol.41: 511-518
[3]  Escherich G, Horstmann MA, Zimmermann M, Jan-ka-Schaub GE(2010): Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.Leukemia. 24(2):298-308
[4]  Eyrich M, Wiegering V, Lim A, Schrauder A, Winkler B, Schlegel PG.(2009): Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 pediatric patients. Br J Haematol. 147(3):360-70
[5]  Gaynon p (2005): Childhood acute lymphocytic leukemia and relapse. Br J Haematol 131 pp.579-587
[6]  Georgala, Sophia, Papassotiriou, Ioannis, Georgala, Catherina, Demetriou, Elisabeth, Schulpis, Kleopatra H. (2005): isotretinoin therapy induces DNA oxidative damage. Genetics and molecular diagnostics. Clinical chemistry & laboratory medicine. 43(11):1178-1182
[7]  Goto H, Yanagimachi M, Kajiwara R and Yokota S (2007): Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphocytic leukemia cells. Leuk Res 31pp. 1301-1309
[8]  Habig WH, Pabst MJ, Fleischner G, Gatmaitan Z, Arias IM, Jakoby WB (1974): "The identity of glutathione S-transferase B with ligandin, a major binding protein of liver". Proc. Natl. Acad. Sci. U.S.A. 71 (10): 3879–82
[9]  He YL, Cao LZ, Yang J, Yang MH, Xu WQ, Xie M, Shi Z. (2009): [Expression of WAVE1 and p22phox in children with acute lymphocytic leukemia and the relationship of WAVE1 with oxidative stress] Zhongguo Dang Dai Er Ke Za Zhi. (2):88-92
[10]  Hempel L, Misselwitz J, Fleck C, Kentouche K, Leder C, Appenroth D, Rost M, Zintl F(2003 ): Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function. Med Pediatr Oncol. 40(6):348-54
[11]  Jemal A, Siegal R, Ward E, MurrayT, Xu J, Smigal C. (2006): CA A Cancer Statistics, 2006 Kour K, Pandey A, Suri KA, Satti NK, Gupta KK, Bani S(2010): Restoration of stress-induced altered T cell function and corresponding cy-tokines patterns by Withanolide A. Int Immunopharmacol. 9(10):1137-44.
[12]  Masutani h (2000): Oxidative stress response and signaling in hematological malignancies and HIV infection. Int J Hemotol 71pp25-32
[13]  Neyestani TR, Fereydouni Z, Hejazi S, Salehi-Nasab F, Na-teghifard F, Maddah M, Karandish M. (2007): Vitamin C status in Iranian children with acute lymphoblastic leukemia: evidence for increased utilization. J Pediatr Gastroenterol Nutr. 45(1):141-4
[14]  Papiez MA, Malgorzata Dybala, Magdalena Sowa-Kucma, Wirginia Krzysciak, Hevidar M. Taha, Alicja, Gabriel Nowak, (2009): Evaluation of oxidative status and depression-like responses in Brown Norway rats with acute myeloid leukemia, Neuro-Psychopharmacology & Biological Psychiatry: 10-16
[15]  Sentürker S, Karahalil B, Inal M, Yilmaz H, Müslümanoglu H, Gedikoglu G, Dizdaroglu M. (1997): Oxidative DNA base damage and antioxidant enzyme levels in childhood acute lymphoblastic leukemia. FEBS Lett. ; 416(3):286-90
[16]  Sharma A, Rajappa M, Saxena A, Sharma M.(2008): Anti-oxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci. 2007; 64(1):23-7
[17]  Valko M, Rhodes C, Monocola M and Mazura M (2006): Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Boil Interact 160 pp. 1 – 40
[18]  Yang Y, Tian Y, Yan C, Jin X, Tang J, Shen X. (2009): De-terminants of urinary 8-hydroxy-2'-deoxyguanosine in Chi-nese children with acute leukemia. Environ Toxicol. (5):446-52
[19]  Zou Y, Zhang X, Mao Y, Lu G, Huang M, Yuan B(2010): Acute toxicity of a single dose DATR, recombinant soluble human TRAIL mutant, in rodents and crab-eating macaques. Hum Exp Toxicol